A professor of biochemistry at Geisinger Commonwealth School of Medicine (Geisinger Commonwealth) contributed to research that led to the Nobel Prize in Medicine awarded Oct. 2 to three U.S. researchers. The prize was awarded to Jeffrey Hall at the University of Maine, Michael Rosbash at Brandeis University and Michael Young at the Rockefeller University for their decades-long work on the circadian clock.
A scientific article published in the journal Cell, listing William Zehring, PhD, professor of biochemistry at Geisinger Commonwealth, as first author, was recognized as a “key publication” by the Nobel Prize committee. The article cited was P-element transformation with period locus DNA restores rhythmicity to mutant arrhythmic Drosophila melanogaster. The article identified a specific portion of the fruit fly’s DNA that controls rhythmic behaviors analogous to sleep and wakefulness, among others. This research was a critical step in verifying that scientists were working with the correct DNA sequence that restored rhythmicity to fruit flies lacking that capability due to a genetic mutation.
About Geisinger Commonwealth School of Medicine
Geisinger Commonwealth School of Medicine (Geisinger Commonwealth) is a member of the Geisinger family. Geisinger Commonwealth offers a community-based model of medical education with campuses in Danville, Doylestown, Scranton, Sayre and Wilkes-Barre. Geisinger Commonwealth offers Doctor of Medicine (MD) and Master of Biomedical Sciences (MBS) degrees. The school’s innovative curriculum, focused on caring for people in the context of their lives and their community, attracts the next generation of physicians and scientists from within its region in northeastern and central Pennsylvania, as well as from across the state and the nation. The school also has over 440 graduate medical students in 24 residency programs and 19 accredited fellowships. Geisinger Commonwealth is committed to non-discrimination in all employment and educational opportunities. For more information, visit www.geisinger.edu/gcsom, or connect with us on Facebook, Instagram, LinkedIn and Twitter.
One of the nation’s most innovative health services organizations, Geisinger serves more than 1.5 million patients in Pennsylvania and New Jersey. The system includes 13 hospital campuses, a nearly 600,000-member health plan, two research centers and the Geisinger Commonwealth School of Medicine. Geisinger is known for its focus on caring and innovative programs including the ProvenCare® best-practice approach to maximize quality, safety and value; ProvenHealth Navigator® advanced medical home; Springboard Health® population health program to improve the health of an entire community; ProvenExperience™ to provide refunds to patients unhappy with their care experience; and Geisinger’s MyCode® Community Health Initiative, the largest healthcare system-based precision health project in the world. With more than 215,000 volunteer participants enrolled, MyCode is conducting extensive research and returning medically actionable results to participants. A physician-led organization, with approximately 32,000 employees and more than 1,800 employed physicians, Geisinger leverages an estimated $12.7 billion positive annual impact on the Pennsylvania and New Jersey economies. Repeatedly recognized nationally for integration, quality and service, Geisinger has a long-standing commitment to patient care, medical education, research and community service. For more information, visit www.geisinger.org, or connect with us on Facebook, Instagram, LinkedIn and Twitter.
For GCSOM media inquiries
Director of Media and Public Relations
Geisinger Commonwealth School of Medicine
On call: 570-687-9703